Rui Tato Marinho Selected Research

Rui Tato Marinho Research Topics

3	Liver Diseases (Liver Disease) 12/2021 - 02/2016
3	Infections 01/2018 - 04/2011
3	Fibrosis (Cirrhosis) 01/2018 - 07/2017
2	Hepatitis C 07/2017 - 10/2013
2	Chronic Hepatitis B 04/2013 - 04/2011
2	Persistent Infection 12/2011 - 04/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022
1	Hepatocellular Carcinoma (Hepatoma) 12/2021
1	Diverticular Diseases 11/2019
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2019
1	Coinfection 01/2018
1	Portal Hypertension 07/2017
1	Chronic Hepatitis (Chronic Active Hepatitis) 08/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 08/2015
1	Liver Neoplasms (Liver Cancer) 08/2015
1	Neoplasms (Cancer) 08/2015
1	Acute Liver Failure (Fulminant Hepatic Failure) 08/2015
1	Allergic Contact Dermatitis 03/2014
1	Pruritus (Itching) 11/2013
1	Benign Migratory Glossitis (Geographic Tongue) 04/2013
1	Rheumatic Diseases (Rheumatism) 04/2011
1	Hepatitis B 04/2011

4	Antiviral Agents (Antivirals)IBA 01/2018 - 04/2011
3	Pharmaceutical PreparationsIBA 01/2018 - 12/2011
2	InterferonsIBA 01/2018 - 07/2017
1	Infliximab (Remicade)FDA Link 10/2022
1	vedolizumabIBA 10/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022
1	Sorafenib (BAY 43-9006)FDA Link 12/2021
1	CopperIBA 01/2019
1	glecaprevir and pibrentasvirIBA 01/2018
1	glecaprevirIBA 01/2018
1	VaccinesIBA 08/2015
1	AllergensIBA 03/2014
1	lysophosphatidic acidIBA 11/2013
1	Tenofovir (Viread)FDA Link 04/2013
1	Transaminases (Aminotransferases)IBA 04/2011
1	Surface Antigens (Surface Antigen)IBA 04/2011
1	DNA (Deoxyribonucleic Acid)IBA 04/2011
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2011

3	Therapeutics 07/2017 - 04/2011
3	Liver Transplantation 02/2016 - 11/2013
1	Ligation 11/2019
1	Palliative Care (Palliative Therapy) 11/2018
1	Length of Stay 02/2016
1	Phototherapy (Light Therapy) 11/2013